16 SUSTAIN-6 Trial: SUSTAIN-6 (Evaluate Cardiovascular and Other Long-term Outcomes with Semaglutide in Subjects with Type 2 Diabetes) Conclusions: The SUSTAIN-6 trial investigated the cardiovascular safety of once-weekly semaglutide injection in subjects with type 2 diabetes and a high risk of adverse cardiovascular events
Millions of people know that GLP-1 receptor agonists could change their trajectory, yet they freeze up the moment they sit down in that exam room
If you want more background on how glutathione levels are produced and maintained, our article on where glutathione is produced is a useful companion read
If side effects are causing anxiety or affecting your day-to-day life, a Slim Shot consult or follow-up visit is an opportunity to pause, reassess, and make sure your treatment plan continues to fit your needs
Managing Side Effects with the Right Foods If you experience gastrointestinal issues or other adverse events, consider adding bland foods like bananas, rice, applesauce, and toast to your GLP-1 nutrition plan
For instance, semaglutide has been approved and is being researched for indications including obesity, T2DM, reducing cardiovascular risk, chronic kidney disease, NAFLD, and AD, indicating that the development of new indications could provide new growth opportunities for GLP-1 drugs